|
Rebecca is Xconomy's cofounder and executive editor. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University. Before becoming a journalist, she worked in the MIT lab of Nobel prizewinning neuroscientist Susumu Tonegawa.
PrimeraDx, a Mansfield, MA-based developer of molecular diagnostic technology, has named Matthew F. McManus as its new president and chief executive, the company announced today. The startup, which raised $20 million... Read more »
[Updated 8/13/2010 9:30 EST. See below.] New England’s biotech and healthcare sector yielded a number of interesting stories this week.
—Joanna Horobin, CEO of Syndax Pharmaceuticals, confirmed that the... Read more »
New England’s tech and life sciences firms had a busy week raising money and inking acquisition deals. So much for the summer slow-down!
—Blue Cod Technologies announced it has raised... Read more »
Rebecca said: WC- The image was meant only to provide a little abstract eye candy, but point taken. Hope the new... Read more »
One of the things I’ve always enjoyed about technology journalism is how cozy a niche it is. There just aren’t than many folks who can geek out with the lab dwellers,... Read more »
The precipitation in New England may have reached near-biblical proportions this past week, but tech and life sciences deal making was more modest.
—Investors poured $10.1 million into Littleton, MA-based... Read more »
This week saw new leadership at a couple of New England’s life sciences companies, some wisdom from one of its newly public companies, and a new truce in one of its... Read more »
The FDA added some suspense to one New England biotech firm’s week, while two others reached closure on nice-sized venture deals.
—Genetix Pharmaceuticals raised $35 million in a Series B... Read more »
Another week, another cadre of CEOs with big plans for growing their New England life sciences companies even bigger.
—Diagnostics For All CEO Una Ryan talked about her multi-pronged effort... Read more »
Deal flow was a bit slow among New England’s tech and life sciences firms this week. Perhaps folks were too distracted by the unexpected appearance of that warm glowing ball in... Read more »
Another eventful week for New England’s life sciences companies, with big changes potentially in store for two of the biggest firms.
—Biogen Idec’s new board chairman, Bill Young, told Luke that... Read more »
It was a good week for venture dealmaking among New England’s tech and life sciences firms.
—Needham, MA-based Stata Venture Partners led a $7 million Series B financing round for NABsys... Read more »
EveryScape announced it has raised $6 million in a Series C funding round led by SK Telecom Americas, a division of Korean mobile operator SK Telecom (NYSE: SKM), and joined... Read more »
New England’s tech and life sciences firms inked lots of deals in the last week, with the software sector being particularly active.
—Advanced RenewableEnergy Company of Nashua, NH, raised $5... Read more »
Posting will be light today as Xconomy is closed for Presidents Day. We’ll be back tomorrow full force. Meanwhile, enjoy the holiday!
This week we’ve got another crop of great interviews with the founders and executives of some of New England’s most fascinating life sciences companies.
—Zafgen CEO Tom Hughes filled Luke... Read more »
It’s only been a few days since I last rounded up the deals news from New England’s tech and life sciences companies, but there are still a few new transactions to... Read more »
For the first time in as long as I can remember, IPOs dominated the New England tech and life sciences deals news this week.
—Glasshouse Technologies, an IT consulting firm in... Read more »
We spent some time this week looking at the data on last year’s venture deals, big and small, while New England’s tech and life sciences companies announced some of the first... Read more »
You know a new hire is a good fit when by the end of her first day you’ve already forgotten that she’s new. And that’s just what happened when our new... Read more »
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, and beyond.
© 2007-2010, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.